• Faculty

    Eva Kubala Havrdová, (Chair), Department of Neurology, Charles University, Prague, Czech Republic
    Patricia Coyle, Comprehensive Care Centre, Stony Brook Medical Sciences Institute, Stony Brook, New York, USA
    Tomas Olsson, Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden
    Jiwon Oh, Keenan Research Centre for Biomedical Science and St Michael’s Hospital, Toronto, Canada

    Programme overview

    The live 1.5-hour symposium was held at the 26th Annual Meeting of the European Charcot Foundation (ECF) on 15 November 2018 in Baveno, Italy

    To view the full agenda please click here

    Target Audience

    This educational activity is intended for any healthcare professionals with a special interest in neurology and multiple sclerosis (MS), including neurologists, neuroscientists and researchers, and allied healthcare professionals, such as MS specialist nurses

    Learning Objectives

    After completing this programme participants will be able to:

    • Identify how ‘measures of success’ guide optimum clinical practice in MS
    • Evaluate the relationship between disease activity and predicted disease course, and how this affects treatment choice in an era of expanding MS therapy options
    • Adapt patient management and maximize the opportunities arising from increasingly targeted approaches in MS
    • Propose partnerships between technology and biology that can – or will – benefit MS diagnosis and monitoring
    • Plan a change to make in practice now in preparation for the future


    This programme has been supported by an independent educational grant from Merck KGaA, Darmstadt, Germany


    The meeting Multiple Sclerosis: Welcome to the future has been accredited by the European Council for Continuing Medical Education (EACCME®) with 1 European CME Credits (ECMEC®s)

    An application will be made to the UEMS-EACCME® for CME accreditation of the post-meeting online materials